ArticlePharmaceuticals (Basel, Switzerland)2025

Repurposing Rosiglitazone Induces Apoptosis Accompanied by Impaired Antioxidant Defense in Cholangiocarcinoma Cells: Findings from Proteomic and Functional Analyses.

Benjaporn Buranrat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.